Axoft Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Axoft Inc. - overview

About

Founded in 2021 by its CEO, Paul Le Floch, CTO, Tianyang Ye, and Scientific Advisor, Jia Liu, and based in Massachusetts, US, Axoft Inc. , operates as a biotechnology company that offers neurological disorder treatment solutions. In October 2022, The Engine led a USD 8 million seed funding for Axoft Inc. , with participation from other investors Ab Initio Capital, AIBasis Fund, Alumni Ventures Group, Amino Capital, Blindspot Ventures, Decent Capital, LiquidMetal Ventures, Mintz and Co.

, Safar Partners, and Taihill Venture. The company offers healthcare solutions by providing implant material, and signal-processing electronics used for amplification, compression, and wireless transmission. The company also provides surgical implantation tools used for precise insertion and navigation, along with decoding software for the interpretation of neural signals. The company plans to use the October 2022 funding for its pre-clinical studies.

Current Investors

Amino Capital, Decent Capital, Alumni Ventures Group

Request a demo

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare IT, Surgical Devices, Medical Software

Website

www.axoft.us

Verticals

HealthTech, Nanotechnology

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo